12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Friday's intraday session, several healthcare stocks experienced significant movements. Intensity Therapeutics (INTS) saw a notable increase of 107.2%, while Conduit Pharmaceuticals (CDT) and ALX Oncology Holdings (ALXO) also saw substantial gains. On the other hand, AquaBounty Techs (AQB), Veradigm (MDRX), and Cano Health (CANO) were among the stocks that declined. These movements reflect the dynamic nature of the healthcare sector and may be influenced by company-specific news or broader market trends.

December 08, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ALX Oncology Holdings stock increased by 34.59% to $12.45, with a market cap of $620.2 million, indicating a bullish trend.
ALXO's stock price jump could be driven by positive news or investor confidence in the company's prospects, suggesting potential for continued short-term appreciation.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Conduit Pharmaceuticals stock rose by 37.53% to $4.87, with a market cap of $359.4 million, reflecting positive market activity.
The significant rise in CDT's stock price could be due to recent company developments or market conditions favoring the stock, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Intensity Therapeutics stock soared by 107.2% to $8.29, with a market cap of $113.6 million, indicating strong investor interest.
The substantial increase in stock price suggests positive investor sentiment or favorable news specific to Intensity Therapeutics, which could lead to continued short-term momentum.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
AquaBounty Techs stock declined by 19.6% to $3.04, with a market cap of $11.6 million, indicating negative market sentiment.
The drop in AQB's stock price suggests adverse events or market reactions, which could lead to further short-term downward pressure on the stock.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Cano Health shares dropped by 16.37% to $9.03, with a market value of $26.0 million, signaling a bearish trend.
The decrease in CANO's share price may be due to negative market news or sentiment, which could continue to affect the stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Veradigm stock fell by 18.99% to $10.2, with a market cap of $1.1 billion, reflecting a bearish market response.
MDRX's decline could be attributed to negative news or investor sentiment, potentially leading to further short-term declines in the stock price.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90